1. Israel Stocks

  2. •

    Finance

  3. •

    Real estate development
Elbit Real Estate Ltd

Elbit Real Estate Ltd

380.30
ILA
-12.20
(-3.11%)
-44.29EPS
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
4.74
50.35
25.27
- -
- -
- -
- -
- -
- -
- -
- -
- -
3.06
4.32
Basic EPS, GAAP
-2,784.91
127.46
-23.51
-21.2
-36.78
-56.34
-11.7
25.01
-2.24
-0.26
-0.27
-0.5
-0.43
-0.43
Free Cash Flow per Basic Share
33.51
34.94
21.18
8.07
46.75
-2.21
-1.61
-1.7
-0.37
-0.04
-0.04
-0.05
0.54
-0.2
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
0.27
1.11
0.14
- -
- -
- -
Book Value per Share
-3,994.2
25.17
2.11
-9.63
-21.16
-4.32
-13.21
10.28
7.72
6.82
-0.07
6.13
5.89
6.62
Tangible Book Value per Share
-3,994.2
25.17
2.11
-9.63
-21.16
-4.32
-13.21
10.28
7.72
6.82
-0.07
6.13
5.89
6.62
Basic Weighted Avg Shares
- -
8
8
9
9
9
9
9
9
9
10
11
12
13
Sales/Revenue/Turnover
2
399
200
- -
- -
- -
- -
- -
- -
- -
- -
- -
38
55
Operating Margin (%)
-2,900.71
-26.84
-53.46
- -
- -
- -
- -
- -
- -
- -
- -
- -
-6.29
2.07
Depreciation Expense
4
583
123
196
120
113
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
-1,156
1,009
-186
-195
-338
-518
-107
230
-20
-2
-3
-5
-5
-5
Effective Tax Rate (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Profit Margin (%)
-58,811.45
253.15
-93.04
- -
- -
- -
- -
- -
- -
- -
- -
- -
-14.03
-9.93
Working Capital
-2,694
102
-589
-1,031
-363
-110
-108
-3
21
35
- -
68
-18
57
LT Debt
- -
756
1,444
853
243
145
159
- -
- -
- -
2
2
71
137
Total Equity
-1,033
232
304
49
-149
-60
-169
94
71
63
-1
68
87
97
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)
- -
- -
-148.12
- -
- -
- -
- -
- -
-24.79
-3.53
- -
- -
-7.22
- -

Capital Structure

ILS

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
187
172
125
LT Borrowings
71
71
137
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
13
13
13
Market Capitalization
- -
- -
- -

Working Capital

ILS

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
204
194
214
Cash, Cash Equivalents & STI
149
145
163
Accounts Receivable, Net
3
- -
4
Inventories
- -
- -
- -
Total Current Liabilities
224
212
157
Payables & Accruals
- -
- -
- -
ST Debt
187
172
125
Deferred Revenue
- -
- -
- -

Growth Rates

ILS

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
-1,055.57%
-2,006.34%
27.1%
Free Cash Flow
- -
- -
-1,244.16%
Net Income, GAAP
-34.59%
-16.83%
-0.71%
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
24
14
38
2026
17
- -
- -
- -
- -

Quarterly Earnings Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
-0.06
-0.31
-0.5
2025
-0.15
-0.07
-0.15
-0.07
-0.43
2026
-0.13
- -
- -
- -
- -

Quarterly Dividends Per Share

ILS

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
2026
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Ron Hadassi
Full Time Employees
20
Sector
Finance
Industry
Real estate development
Address
3 Shimson Street Petach Tikva Israel 4900102
IPO Date
Nov 1, 1996
Website
emetalslimited.com.au
Similar Companies
DLF Limited (NSE:DLF)
Opendoor Technologies Inc (NASDAQ:OPEN)
Samolet (MOEX:SMLT)
Alarko Holding A.S. (BIST:ALARK)
Godrej Properties Limited (NSE:GODREJPROP)
Lodha Developers Ltd. (NSE:LODHA)
Business
Elbit Imaging Ltd. (TASE: EMITF-M, OTC: EMITF) operates as a shell company with no significant current operations; it functions primarily as an investment holding entity with residual interests in real estate projects in India and medical instruments in Israel. The company, formerly known as Elbit Medical Imaging Ltd., previously developed and sold medical systems including therapeutic ultrasound treatment equipment incorporating magnetic resonance imaging for non-invasive human body treatments and stem cell expansion technologies derived from umbilical cord blood for bone marrow transplantation in leukemia, non-malignant blood diseases, and metabolic genetic conditions; it also held stakes in commercial centers, hotels such as the Radisson Blu and Park Inn in Romania and Belgium, and plots for residential development. Founded in 1996 and headquartered in Bnei Brak, Israel, Elbit Imaging maintains a minimal staff of three employees and focuses on real estate in Central and Eastern Europe as well as India, alongside dormant medical segments. Recent activities include reporting a net loss of ILS 1.82 million for the third quarter ended September 30, 2025, up from ILS 0.676 million the prior year, alongside an annual general meeting in November 2025 and ongoing note buyback programs; the company executed a 1-for-10 reverse stock split effective June 2024 and sold Elbit Medical shares to Exigent Capital for $5 million in a prior transaction, reflecting its strategy to streamline holdings post-2007 name change and historical asset disposals like the 2015 sale of Belgian hotels to KKR.